You searched for "laser"

1368 results found

BAUN Symposium: The prostate cancer treatment nurses aren’t talking about – but should be

Free to attend with registration pass. Presenter: Claire Deering, Prostate/Brachytherapy Nurse Specialist, Royal Surrey County Hospital, Chair: Donna Higgins, Lead Urology Nurse Specialist, Royal Surrey County Hospital

SIU (45th Congress of the Société Internationale d’Urologie)

29 October - 1 November

Biomarkers in prostate cancer detection

Prostate cancer (PCa) is the second most common cancer in men with an estimated prevalence of 1.1 million worldwide in 2012. This heterogeneous disease resulted in approximately 307,000 deaths, making it the fifth leading cause of cancer-related death in men...

EAU Guidelines App

The European Association of Urology (EAU) continues to lead on the latest guidelines within urology. The all new EAU guidelines app brings together the pocket version of the EAU guidelines with a much improved user interface. Both the cancer and...

The Malcolm Coptcoat Travelling Fellowship Award

The Urology Foundation and The Malcolm Coptcoat Trust are pleased to announce the creation of The Malcolm Coptcoat Travelling Fellowship. The annual Fellowship will support travel to international centres of excellence for a period of four to six weeks to...

Occupational tumours of the urinary tract: The work of Denis Poole-Wilson

In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would be taking you to the...

Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction

Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...

The role of PET-CT imaging in prostate cancer

Prostate cancer (PCa) is the second most common cancer in the UK, with 43,000 cases in 2017-18 [1,2]. Accurate primary staging and the detection of suspected recurrence following treatment is vital for directing management and predicting prognosis. This has conventionally...